Stoppelli, Maria Patrizia
 Distribuzione geografica
Continente #
AS - Asia 79
SA - Sud America 55
NA - Nord America 54
EU - Europa 51
AF - Africa 1
Totale 240
Nazione #
SG - Singapore 64
BR - Brasile 51
IT - Italia 43
US - Stati Uniti d'America 35
MX - Messico 18
HK - Hong Kong 9
FR - Francia 5
BD - Bangladesh 2
CO - Colombia 2
GB - Regno Unito 2
AR - Argentina 1
AZ - Azerbaigian 1
BB - Barbados 1
CN - Cina 1
PY - Paraguay 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 240
Città #
Singapore 64
Rome 38
Mexico City 16
Hong Kong 9
Dax 5
Santa Clara 5
Belo Horizonte 2
Curitiba 2
Houston 2
Itabuna 2
Rio de Janeiro 2
Akşehir 1
Alegrete 1
Aparecida de Goiânia 1
Araras 1
Atlanta 1
Bagé 1
Baku 1
Barranquilla 1
Barreiras 1
Beijing 1
Belém 1
Birigui 1
Boardman 1
Bragança Paulista 1
Brasília 1
Bridgetown 1
Brooklyn 1
Cajamar 1
Cajazeiras 1
Camaçari 1
Camden 1
Caém 1
Charlotte 1
Ciudad de Villa de Álvarez 1
Ciudad del Este 1
Colatina 1
Conceição do Mato Dentro 1
Criciúma 1
Cristino Castro 1
Dayton 1
Daytona Beach 1
Edmond 1
Fortaleza 1
Goiânia 1
Green Bay 1
Guarapuava 1
Hackney 1
Hortolândia 1
Jacobina 1
London 1
Longchamps 1
Lucas do Rio Verde 1
Makkah 1
Manaus 1
Mateus Leme 1
Medellín 1
Middletown 1
Montgomery 1
Morelia 1
Moscow 1
Natal 1
North Port 1
Palmeira das Missões 1
Paranavaí 1
Pelotas 1
Perry 1
Providence 1
Queens 1
Recife 1
Rio Grande 1
Rio das Ostras 1
Saidpur 1
Salto 1
Salvador 1
Santa Albertina 1
Santo Augusto 1
Secaucus 1
Sorocaba 1
South Bend 1
São Luís 1
São Paulo 1
São Vicente 1
Taboão da Serra 1
Teófilo Otoni 1
Timbó 1
Turin 1
Woodstock 1
Totale 224
Nome #
Developmental regulation of an insulin degrading enzyme in Drosophila melanogaster 10
A recombinant pro-urokinase missing the growth factor-like domain does not bind the urokinase receptor 10
Protein kinase C-dependent in vivo phosphorylation of prourokinase leads to the formation of a receptor competitive antagonist 9
MCT4-driven CAF-mediated metabolic reprogramming in breast cancer microenvironment is a vulnerability targetable by miR-425-5p 9
Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide 8
Differentiation-enhanced binding of the aminoterminal fragment of of human urokinase plasminogen activator to a specific receptor on U937 monocytes 8
An insulin epidermal growth factor-binding protein from Drosophila has insulin-degrading activity 8
Inhibition of Sp1 activity by a decoy PNA-DNA chimera prevents urokinase receptor expression and migration of breast cancer cells 7
Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA 7
In vitro receptor imaging for characterization of human solid tumors 7
Autocrine saturation of pro-urokinase receptors on human A431 cells 7
Activation of urokinase receptor by a novel interaction between the connecting peptide region of urokinase and αvβ5 integrin 7
Inhibition of migration and invasion of carcinoma cells by urokinase-derived antagonists of αvβ5 integrin activation 7
Modulation of cellular migration and survival by c-Myc through the downregulation of urokinase (uPA) and uPA receptor 6
Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies 6
RhoB regulates uPAR signalling 6
Molecular cloning of human urokinase cDNA: transcriptional regulation in A431 cells 6
Urokinase receptor-dependent and independent p56/59hck activation state is a molecular switch between myelomonocytic cell motility and adherence 5
Urokinase receptor interacts with αvβ5 vitronectin receptor promoting urokinase-dependent cell migration in breast cancer 5
The urokinase receptor: structure, regulation and inhibitor-mediated internalization 5
Histone deacetylase inhibitors impair vasculogenic mimicry from glioblastoma cells 5
An urokinase receptor antagonist that inhibits cell migration by blocking the formyl peptide receptor 5
Characterization of a Drosophila protein that binds both Epidermal Growth Factor and insulin-related growth factors 5
Urokinase receptor promotes ovarian cancer cell dissemination through its ser88-arg-ser-arg-tyr92 chemotactic sequence 5
Inhibition of receptor-dependent urokinase signaling by specific ser to glu substitutions 5
Vitronectin binding to urokinase receptor in human breast cancer 5
Inhibiting monocyte recruitment to prevent the pro-tumoral activity of tumor-associated macrophages in chondrosarcoma 5
Phosphorylation of pro-urokinase on Ser138/303 impairs its receptor-dependent ability to promote myelomonocytic adhesion and motility 5
Phosphorylation of urokinase is not a limiting step in biosynthesis, but results in a reduced PAI-1 sensitivity 5
MiR-204 targeting of Ankrd13A controls both mesenchymal neural crest and lens cell migration 4
Structure, function and antagonists of urokinase-type plasminogen activator 4
A novel localization in human large extracellular vesicles for the EGF-CFC founder member CRIPTO and its biological and therapeutic implications 4
Dp100 EGF and insulin binding protein from Drosophila cells 4
Engineered antagonists of uPA and PAI-1 4
Engaged urokinase receptors enhance tumor breast cell migration and invasion by upregulating αvβ5 vitronectin receptor cell surface expression 4
Urokinase signalling through its receptor protects against anoikis by increasing Bcl-xL expression levels 4
Human urokinase receptor concentration in malignant and benign breast tumors by in vitro quantitative autoradiography. Comparison with urokinase levels 4
Targeting the cross-talk between Urokinase receptor and Formyl peptide receptor type 1 to prevent invasion and trans-endothelial migration of melanoma cells 4
A reversible shift of driver dependence from EGFR to Notch1 in non-small cell lung cancer as a cause of resistance to tyrosine kinase inhibitors 4
Analysis of secretome changes uncovers an autocrine/paracrine component in the modulation of cell proliferation and motility by c-Myc 4
Nuovi peptidi e peptidomimetici come agenti potenti e mirati nella prevenzione e nel trattamento dell'invasione e metastasi tumorali 4
Proteases and cancer invasion: from belief to certainty 3
Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma 3
Phosphorylation of seminal vesicle protein IV on Ser58 enhances its peroxidase-stimulating activity 3
Increase in urokinase plasminogen activator mRNA in human carcinoma cells is a primary effect of the potent tumor promoter phorbol myristate acetate 3
Separation and characterization of non phosphorylated and serine phosphorylated pro-urokinase.Catalytic properties and sensitivity to PAI-1 3
The receptor binding sequence of urokinase: biological function for the growth factor module of proteases 3
Reversal of Warburg effect and reactivation of oxidative phosphorylation by differential inhibition of EGFR signaling pathways in non small cell lung cancer 3
An urokinase receptor-derived peptide inhibiting VEGF-dependent directional migration and vascular sprouting 3
Single amino acid substitutions in the chemotactic sequence of urokinase receptor modulate cell migration and invasion 3
Breast tumor cell invasion and pro-invasive activity of cancer-associated fibroblasts co-targeted by novel urokinase-derived decapeptides 3
Upregulation of epidermal growth factor receptor induced by alpha-interferon in human epidermoid cancer cells 3
The urokinase plasminogen activator and its receptor: role in cell growth and apoptosis 3
Optic nerve head and fibre layer imaging for diagnosing glaucoma 2
Molecular basis for plasminogen activation, surface proteolysis and their relation to cancer 2
Developmental regulation of an insulin/ EGF binding protein in Drosophila 2
Transcriptional induction of urokinase in cultured human kidney carcinoma cells by tetradecanoyl-phorbol acetate 2
Serine phosphorylation of biosynthetic human urokinase plasminogen activator 2
Biological role and clinical relevance of extracellular vesicles as key mediators of cell communication in cancer 2
The urokinase-type plasminogen activator and the generation of inhibitors of urokinase activity and signaling 2
Paracrine recruitment and activation of fibroblasts by c-Myc expressing breast epithelial cells through the IGF/IGF-1R axis 2
The soluble form of urokinase receptor promotes angiogenesis through its Ser⁸⁸-Arg-Ser-Arg-Tyr⁹² chemotactic sequence 2
The Plasminogen Activation System in Cell Invasion 2
EGF and insulin related growth factors compete for binding to a single Drosophila protein 2
Structure-based design of an urokinase-type plasminogen activator receptor-derived peptide inhibiting cell migration and lung metastasis 2
The receptor for human urokinase-plasminogen activator 2
Praf2 is a novel Bcl-xL/Bcl-2 interacting protein with the ability to modulate survival of cancer cells 2
Preliminary studies on the structure and regulation of the human urokinase gene: effect of tumor promoters, EGF and transformation by SV40 2
Specificity and properties of the human urokinase receptor 2
Modulation of cellular function by the urokinase receptor signalling: a mechanistic view 2
Exosomal microRNAs synergistically trigger stromal fibroblasts in breast cancer 2
Molecular biology of plasminogen activation and its role in the invasivness of malignant cells 2
Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion 2
The receptor binding sequence of human urokinase 1
Regulation of cell migration and invasion by specific modules of uPA: mechanistic insights and specific inhibitors 1
αV-Integrin-Dependent Inhibition of Glioblastoma Cell Migration,Invasion and Vasculogenic Mimicry by the uPAcyclin Decapeptide 1
Phorbol ester PMA regulates the affinity and the number of the urokinase receptors in monocyte-like U937 cells 1
Opposite modulation of cell migration by distinct subregions of urokinase connecting peptide 1
PHOSPHORYLATED PLASMINOGEN ACTIVATORS AND NOVEL MUTEINS RELATED TO THE PHOSPHORYLATED PLASMINOGEN ACTIVATORS 1
Totale 318
Categoria #
all - tutte 998
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 998


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025318 0 0 0 0 0 0 0 1 1 117 156 43
Totale 318